These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35511415)

  • 1. Comprehensive molecular profiling of pancreatic ductal adenocarcinoma in FNA, biopsy, and resection specimens.
    Razzano D; Bouza SJ; Hernandez PV; Wang M; Robert ME; Walther Z; Cai G
    Cancer Cytopathol; 2022 Sep; 130(9):726-734. PubMed ID: 35511415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adequacy evaluation and use of pancreatic adenocarcinoma specimens for next-generation sequencing acquired by endoscopic ultrasound-guided FNA and FNB.
    Gan Q; Roy-Chowdhuri S; Duose DY; Stewart JM; Coronel E; Bhutani MS; Lee JH; Weston B; Ge PS; Ross WA; Maitra A
    Cancer Cytopathol; 2022 Apr; 130(4):275-283. PubMed ID: 34905283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. K-ras mutation analysis of residual liquid-based cytology specimens from endoscopic ultrasound-guided fine needle aspiration improves cell block diagnosis of pancreatic ductal adenocarcinoma.
    Sekita-Hatakeyama Y; Nishikawa T; Takeuchi M; Morita K; Takeda M; Hatakeyama K; Nakai T; Uchiyama T; Itami H; Fujii T; Mitoro A; Sho M; Ohbayashi C
    PLoS One; 2018; 13(3):e0193692. PubMed ID: 29494669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of endoscopic ultrasound tissue acquisition methods for genomic analysis of pancreatic cancer.
    Elhanafi S; Mahmud N; Vergara N; Kochman ML; Das KK; Ginsberg GG; Rajala M; Chandrasekhara V
    J Gastroenterol Hepatol; 2019 May; 34(5):907-913. PubMed ID: 30422342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FNA smears of pancreatic ductal adenocarcinoma are superior to formalin-fixed paraffin-embedded tissue as a source of DNA: Comparison of targeted KRAS amplification and genotyping in matched preresection and postresection samples.
    Hartley CP; Mahajan AM; Selvaggi SM; Rehrauer WM
    Cancer Cytopathol; 2017 Nov; 125(11):838-847. PubMed ID: 29024530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KRAS mutation testing on all non-malignant diagnosis of pancreatic endoscopic ultrasound-guided fine-needle aspiration biopsies improves diagnostic accuracy.
    Trisolini E; Armellini E; Paganotti A; Veggiani C; Bozzola C; Frattini M; Pizio C; Mancuso G; Andorno S; Boldorini R
    Pathology; 2017 Jun; 49(4):379-386. PubMed ID: 28450086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoscopic Ultrasound-Guided Fine-Needle Biopsy Versus Aspiration for Tissue Sampling Adequacy for Molecular Testing in Pancreatic Ductal Adenocarcinoma.
    Mohamed WT; Jahagirdar V; Jaber F; Ahmed MK; Fatima I; Bierman T; Fu Z; Jones PG; Hassan AF; Faber E; Clarkston WK; Ghoz H; Tawfik OW; Jonnalagadda S
    Cancers (Basel); 2024 Feb; 16(4):. PubMed ID: 38398152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of endoscopic ultrasound-guided fine-needle biopsy versus fine-needle aspiration for genomic profiling and DNA yield in pancreatic cancer: a randomized crossover trial.
    Kandel P; Nassar A; Gomez V; Raimondo M; Woodward TA; Crook JE; Fares NS; Wallace MB
    Endoscopy; 2021 Apr; 53(4):376-382. PubMed ID: 32767288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Routine Molecular Profiling in Both Resectable and Unresectable Pancreatic Adenocarcinoma: Relevance of Cytologic Samples.
    Redegalli M; Grassini G; Magliacane G; Pecciarini L; Schiavo Lena M; Smart CE; Johnston RL; Waddell N; Maestro R; Macchini M; Orsi G; Petrone MC; Rossi G; Balzano G; Falconi M; Arcidiacono PG; Reni M; Doglioni C; Cangi MG
    Clin Gastroenterol Hepatol; 2023 Oct; 21(11):2825-2833. PubMed ID: 36280101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted next generation sequencing of endoscopic ultrasound acquired cytology from ampullary and pancreatic adenocarcinoma has the potential to aid patient stratification for optimal therapy selection.
    Gleeson FC; Kerr SE; Kipp BR; Voss JS; Minot DM; Tu ZJ; Henry MR; Graham RP; Vasmatzis G; Cheville JC; Lazaridis KN; Levy MJ
    Oncotarget; 2016 Aug; 7(34):54526-54536. PubMed ID: 27203738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Echoendoscopic ultrasound pancreatic adenocarcinoma diagnosis and theranostic approach: should
    Béchade D; Palmieri LJ; Bonhomme B; Pernot S; Léna J; Fonck M; Pesqué S; Boillet G; Italiano A; Roseau G
    Therap Adv Gastroenterol; 2024; 17():17562848231224943. PubMed ID: 38250014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KRAS mutation analysis of washing fluid from endoscopic ultrasound-guided fine needle aspiration improves cytologic diagnosis of pancreatic ductal adenocarcinoma.
    Park JK; Lee YJ; Lee JK; Lee KT; Choi YL; Lee KH
    Oncotarget; 2017 Jan; 8(2):3519-3527. PubMed ID: 27974679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Droplet digital polymerase chain reaction detection of KRAS mutations in pancreatic FNA samples: Technical and practical aspects for routine clinical implementation.
    Mansour Y; Boubaddi M; Odion T; Marty M; Belleannée G; Berger A; Subtil C; Laurent C; Dabernat S; Amintas S
    Cancer Cytopathol; 2024 May; 132(5):274-284. PubMed ID: 38308613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reliable Detection of Somatic Mutations for Pancreatic Cancer in Endoscopic Ultrasonography-Guided Fine Needle Aspirates with Next-Generation Sequencing: Implications from a Prospective Cohort Study.
    Habib JR; Zhu Y; Yin L; Javed AA; Ding D; Tenior J; Wright M; Ali SZ; Burkhart RA; Burns W; Wolfgang CL; Shin E; Yu J; He J
    J Gastrointest Surg; 2021 Dec; 25(12):3149-3159. PubMed ID: 34244950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation and diagnostic value of next-generation sequencing analysis of residual liquid-based cytology specimens of pancreatic masses.
    Sekita-Hatakeyama Y; Fujii T; Nishikawa T; Mitoro A; Sawai M; Itami H; Morita K; Uchiyama T; Takeda M; Sho M; Yoshiji H; Hatakeyama K; Ohbayashi C
    Cancer Cytopathol; 2022 Mar; 130(3):202-214. PubMed ID: 34665935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The diagnostic utility of methylthioadenosine phosphorylase immunohistochemistry for pancreatic ductal adenocarcinoma in FNA and small biopsy specimens.
    Yu S; Doyle LA; Hornick JL; Mito JK
    Cancer Cytopathol; 2024 Feb; 132(2):87-95. PubMed ID: 38054349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between EUS-guided fine-needle aspiration cytology and EUS-guided fine-needle biopsy histology for the evaluation of pancreatic neuroendocrine tumors.
    Crinò SF; Ammendola S; Meneghetti A; Bernardoni L; Conti Bellocchi MC; Gabbrielli A; Landoni L; Paiella S; Pin F; Parisi A; Mastrosimini MG; Amodio A; Frulloni L; Facciorusso A; Larghi A; Manfrin E
    Pancreatology; 2021 Mar; 21(2):443-450. PubMed ID: 33390343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KRAS Mutation Testing on Endoscopic Ultrasound-Guided Fine-Needle Aspiration Samples Improves the Diagnostic Accuracy of Pancreatic Cancer.
    Yeung MCF; Shek TWH
    Pancreas; 2022 Nov-Dec 01; 51(10):1365-1371. PubMed ID: 37099780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endoscopic ultrasound-guided sampling of solid pancreatic masses: 22-gauge aspiration versus 25-gauge biopsy needles.
    Yang MJ; Yim H; Hwang JC; Lee D; Kim YB; Lim SG; Kim SS; Kang JK; Yoo BM; Kim JH
    BMC Gastroenterol; 2015 Sep; 15():122. PubMed ID: 26419845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Native Aspirates and Cytological Smears Obtained by EUS-Guided Biopsies for Effective DNA/RNA Marker Testing in Pancreatic Cancer.
    Benesova L; Halkova T; Bunganic B; Belsanova B; Zavoral M; Traboulsi E; Minarik M
    Pathol Oncol Res; 2020 Jan; 26(1):379-385. PubMed ID: 30361898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.